Iwona W. Beczkowska, Ph.D.

Executive Director for Business Development, Ph.D.

Dr. Iwona W. Beczkowska, PhD, is a seasoned executive with over 20 years of experience bridging academic science, pharma/biotech industry, and the financial sector expertise.

Most recently, Dr. Beczkowska served as Sr. Vice President of Investment Banking at the San Diego branch of Gar Wood Securities, LLC. While there, she led client engagements on both issuer and investor sides in the life sciences sector, focusing on capital raise and private placements. Earlier, she served as the Director of Life Sciences Group representing New York-based Wombat Capital, LLC in Southern California focusing on M&A transactions.

Dr. Beczkowska's career accomplishments include but are not limited to: Chairing Research Assessment Committee at Purdue Pharma where she also formed and led several Therapeutic Area Teams; participating in product development strategic decisions; performing assessments and making recommendations in context of licensing opportunities and portfolio expansion. Later, Dr. Beczkowska drove efforts to launch a US presence of the Barcelona-based Laboratorios Esteve; established Scientific Advisory Board at Elan Pharmaceuticals, and engaged in numerous licensing and M&A transactions as an executive employee of several private, public, and VC-backed startup companies including AlgoRx Pharmaceuticals and Forest Laboratories.

Dr. Beczkowska obtained her MS in Psychology from Queens College and her PhD in Neuroscience from CUNY.  She completed her Postdoctoral Associateship in Molecular Pharmacology at Cornell University Medical College in New York City. Dr. Beczkowska also held FINRA series 79, 63, and 82 licenses. She is fluent in several languages and is well versed in cross-cultural integration.